You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
博騰股份(300363.SZ):子公司蘇州博騰B輪融資5.2億元
格隆匯 08-19 19:14

格隆匯8月19日丨博騰股份(300363.SZ)公佈,為促進公司基因細胞治療CDMO業務發展,滿足二級控股子公司蘇州博騰生物製藥有限公司(簡稱“蘇州博騰”)後續發展中資本性支出及運營支出的資金需求,提升蘇州博騰的整體競爭力,公司、公司全資子公司博騰生物研究院、蘇州博騰、博信生物、先進製造二期基金、高瓴辰鈞、惠每健康、南京瑞聯、蘇州時節啟揚、蘇州博浩、蘇州博正、重慶博誠、蘇州博航、蘇州博昌擬與招商一期新產基金、招商資本、招華招證、寧波粵民投、惠每仁鴻、南京星健睿贏、海南瑞聯、福州匯富共同簽署《關於蘇州博騰生物製藥有限公司之B輪投資協議》、《關於蘇州博騰生物製藥有限公司之B輪股東協議》。

該次蘇州博騰B輪融資總額為5.2億元,其中B輪外部投資方擬按照上述協議約定對蘇州博騰增資4億元;同時,公司擬對博騰生物研究院增資1.2億元,用於其按照上述協議約定對蘇州博騰進行增資1.2億元。

Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account